Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Chronic Hepatitis C Virus”

Showing 8 of 0 results

Post-approval studies (Phase 4)Study completedNCT00993122
What this trial is testing

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

Who this might be right for
Hepatitis C
University of Roma La Sapienza 100
Post-approval studies (Phase 4)WithdrawnNCT02959359
What this trial is testing

DAA in the Risk of Recurrence After Curative Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Post-approval studies (Phase 4)Study completedNCT00375661
What this trial is testing

Low-dose Peg-interferon Plus Ribavirin (IFN/RBV) for Prevention of Hepatocellular Carcinoma (HCC) Recurrence in Patients Who Had Surgery to Remove Primary HCC

Who this might be right for
Hepatitis C, Chronic
Kyoto University 100
Large-scale testing (Phase 3)Ended earlyNCT00375895
What this trial is testing

Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation

Who this might be right for
Chronic Hepatitis CEvidence of Liver Transplantation
Rennes University Hospital 11
Testing effectiveness (Phase 2)Study completedNCT01687270
What this trial is testing

Safety and Efficacy of Sofosbuvir and Ribavirin in Adults With Recurrent Chronic Hepatitis C Virus (HCV) Post Liver Transplant

Who this might be right for
Recurrent Chronic Hepatitis C VirusPost Liver Transplant
Gilead Sciences 40
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Large-scale testing (Phase 3)UnknownNCT00299923
What this trial is testing

Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, ChronicRelapse
University of Hamburg-Eppendorf 300
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation